ENDI News and Press, ENDI Corp Com

2026-01-21 21:35:00 ET The following segment was excerpted from the Cedar Creek Partners Q4 2025 Letter. ... Read the full article on Seeking Alpha For further details see: ENDI Corp.: Reported Numbers Do Not Reflect What Is Happening

2025-10-22 04:00:00 ET The following segment was excerpted from Cedar Creek Partners' Q3 2025 Results We profiled ENDI Corp. ( ENDI ) in our 2024 first quarter letter when the share price was around $6.50 per share. The...

2025-07-25 04:00:00 ET Dear Partner, Arquitos returned 13.1% net of fees in the second quarter of 2025, bringing the year-to-date return to 28.8%. Individual returns will vary based on timing of investment. Please check your statement for specific results. S...

2025-05-19 09:45:00 ET Summary Our fund embraces concentrated holdings, diverging from the passive, diversified approach of mainstream indices like the Russell 2000. Key investments include hyper-concentrated positions in CTT Correios de Portugal, Carvana, and CrossingBridge Advis...

2025-04-30 09:30:00 ET Summary ENDI Corp's shares rose significantly, driven by a substantial increase in AUM and a value-unlocking transaction, suggesting further upside potential. Finch Therapeutics awaits a post-trial decision that could significantly impact its share value, wi...

2025-04-25 06:30:00 ET Summary Arquitos returned 13.8% net of fees in Q1 2025 and is up an estimated 30% year-to-date despite market turmoil. I am highly confident in our top four positions, which are uncorrelated to general markets and have strong company-specific catalysts. ...

2025-04-16 00:30:00 ET Summary Cedar Creek’s average annual return over our 19-year history is 14.3%, net of fees and expenses, which compares favorably to all the indices we compare against. On the whole, as of the end of March 2025, the fund’s holdings were trading...

2025-02-11 05:10:00 ET Summary Cedar Creek’s average annual return over our 19 year history is 14.0%, net of fees and expenses, which compares favorably to all the indices we compare against. We started the quarter with cash levels at 3% and ended the quarter at 8% largely ...

2025-02-05 07:10:00 ET Summary Arquitos Fund achieved a 29.6% return in 2024, outperforming the S&P 500's 25.0% return, driven by strategic investments in key positions. Finch Therapeutics, a 7% portfolio holding, won a significant patent case, potentially leading to enhanced ...

2025-01-29 08:30:00 ET Summary CrossingBridge Advisors, LLC is a wholly-owned subsidiary of ENDI Corp. CrossingBridge’s investment strategies are as follows: ultra-short duration, low duration high yield, responsible credit, and special purpose acquisition companies (SPACs). ...